296 related articles for article (PubMed ID: 23317195)
1. Diagnostic value of human epididymis protein 4 compared with mesothelin for ovarian cancer: a systematic review and meta-analysis.
Lin JY; Qin JB; Li XY; Dong P; Yin BD
Asian Pac J Cancer Prev; 2012; 13(11):5427-32. PubMed ID: 23317195
[TBL] [Abstract][Full Text] [Related]
2. Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis.
Lin J; Qin J; Sangvatanakul V
Eur J Obstet Gynecol Reprod Biol; 2013 Mar; 167(1):81-5. PubMed ID: 23228410
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysis.
Wu L; Dai ZY; Qian YH; Shi Y; Liu FJ; Yang C
Int J Gynecol Cancer; 2012 Sep; 22(7):1106-12. PubMed ID: 22854652
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of HE4 in ovarian cancer: A meta-analysis.
Huang J; Chen J; Huang Q
Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():35-42. PubMed ID: 30317143
[TBL] [Abstract][Full Text] [Related]
5. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.
Li F; Tie R; Chang K; Wang F; Deng S; Lu W; Yu L; Chen M
BMC Cancer; 2012 Jun; 12():258. PubMed ID: 22712526
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of HE4 for ovarian cancer: a meta-analysis.
Yu S; Yang HJ; Xie SQ; Bao YX
Clin Chem Lab Med; 2012 Feb; 50(8):1439-46. PubMed ID: 22868811
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.
Zhen S; Bian LH; Chang LL; Gao X
Mol Clin Oncol; 2014 Jul; 2(4):559-566. PubMed ID: 24940495
[TBL] [Abstract][Full Text] [Related]
8. Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis.
Madeira K; Dondossola ER; Farias BF; Simon CS; Alexandre MC; Silva BR; Rosa MI
An Acad Bras Cienc; 2016 May; 88(2):923-32. PubMed ID: 27254448
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic accuracy of HE4 in lung cancer: a meta-analysis.
Cheng D; Sun Y; He H
Dis Markers; 2015; 2015():352670. PubMed ID: 25873748
[TBL] [Abstract][Full Text] [Related]
10. Serum human epididymis protein 4 vs. carbohydrate antigen 125 and their combination for endometrial cancer diagnosis: a meta-analysis.
Chen Y; Ren YL; Li N; Yi XF; Wang HY
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):1974-85. PubMed ID: 27249595
[TBL] [Abstract][Full Text] [Related]
11. Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.
Shah CA; Lowe KA; Paley P; Wallace E; Anderson GL; McIntosh MW; Andersen MR; Scholler N; Bergan LA; Thorpe JD; Urban N; Drescher CW
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1365-72. PubMed ID: 19423517
[TBL] [Abstract][Full Text] [Related]
12. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses.
Abdel-Azeez HA; Labib HA; Sharaf SM; Refai AN
Asian Pac J Cancer Prev; 2010; 11(1):111-6. PubMed ID: 20593939
[TBL] [Abstract][Full Text] [Related]
13. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
Cui Y; Hong S; Zhu X
Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis.
Yang Z; Wei C; Luo Z; Li L
Onco Targets Ther; 2013; 6():957-66. PubMed ID: 23901285
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the diagnostic accuracy of HE4 for endometrial carcinoma.
Liu J; Han L; Sun Q; Li Y; Niyazi M
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():404-411. PubMed ID: 32711295
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of serum human epididymis protein 4, carbohydrate antigen 125 and their combination in endometrial cancer: A meta-analysis.
Wu Q; Bai SN; Song LY; Wu WF; Han LN
Medicine (Baltimore); 2023 Aug; 102(33):e34737. PubMed ID: 37603503
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of urine HE4 in patients with ovarian cancer: a meta-analysis.
Jia MM; Deng J; Cheng XL; Yan Z; Li QC; Xing YY; Fan DM; Tian XY
Oncotarget; 2017 Feb; 8(6):9660-9671. PubMed ID: 28039447
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic accuracy of human epididymis protein 4 (HE4) for discriminating between benign and malignant pelvic masses: a systematic review and meta-analysis.
Olsen M; Lof P; Stiekema A; van den Broek D; Wilthagen EA; Bossuyt PM; Lok CAR
Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1788-1799. PubMed ID: 34212386
[TBL] [Abstract][Full Text] [Related]
19. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
20. Human epididymis protein 4 in endometrial cancer: A meta-analysis.
Li LM; Zhu YX; Zhong Y; Su T; Fan XM; Xi Q; Li MY; Fu J; Tan H; Liu S
Clin Chim Acta; 2018 Jul; 482():215-223. PubMed ID: 29630870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
